Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Endocrine 1CNS 1

Conditions

Squamous Cell Carcinoma of Head and Neck 630Head and Neck Neoplasms 609Carcinoma, Non-Small-Cell Lung 201Thyroid Neoplasms 196Melanoma 145Nasopharyngeal Carcinoma 133Oropharyngeal Neoplasms 130Colorectal Neoplasms 127Mouth Neoplasms 126Neoplasms 112Breast Neoplasms 112Lung Neoplasms 106Ovarian Neoplasms 104Uterine Cervical Neoplasms 99Neoplasm Metastasis 93Carcinoma, Squamous Cell 85Carcinoma, Renal Cell 83Stomach Neoplasms 82Triple Negative Breast Neoplasms 76Pancreatic Neoplasms 71Esophageal Neoplasms 69Laryngeal Neoplasms 68Endometrial Neoplasms 65Urinary Bladder Neoplasms 59Sarcoma 57Thyroid Cancer, Papillary 54Prostatic Neoplasms 52Salivary Gland Neoplasms 49Carcinoma, Transitional Cell 46Carcinoma, Hepatocellular 45

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Movement Disorders × Head & Neck × 1 year × Clear all
NCT07595666 2026-05-19

Comparison of NeuroEXPLORER PET/CT Versus Standard-of-care PET/CT of the Head and Neck Region.

Universitaire Ziekenhuizen KU Leuven

Phase NA Enrolling by invitation
1,600 enrolled
CNSEndocrineHead & Neck

Amyotrophic Lateral Sclerosis, Brain Neoplasms, Dementia, Epilepsy, Head and Neck Neoplasms, Movement Disorders, Neuroblastoma, Parathyroid Neoplasms, Parkinson Disease, Pituitary Neoplasms, Lewy Body Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡